Search details
1.
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.
Circulation
; 149(12): 932-943, 2024 03 19.
Article
in English
| MEDLINE | ID: mdl-38264923
2.
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.
Am Heart J
; 269: 179-190, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38160917
3.
Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock.
J Card Fail
; 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38513886
4.
Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network.
J Card Fail
; 2024 Feb 21.
Article
in English
| MEDLINE | ID: mdl-38387758
5.
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Eur Heart J
; 44(4): 293-300, 2023 01 21.
Article
in English
| MEDLINE | ID: mdl-36303404
6.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36036760
7.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Article
in English
| MEDLINE | ID: mdl-34985309
8.
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
Am Heart J
; 258: 149-156, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36669711
9.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Article
in English
| MEDLINE | ID: mdl-33587654
10.
The Intersection Between Heart Failure and Critical Care Cardiology: An International Perspective on Structure, Staffing, and Design Considerations.
J Card Fail
; 28(12): 1703-1716, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35843489
11.
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network.
J Card Fail
; 28(4): 675-681, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35051622
12.
Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association.
Circulation
; 142(22): e379-e406, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33115261
13.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
N Engl J Med
; 379(12): 1107-1117, 2018 09 20.
Article
in English
| MEDLINE | ID: mdl-30145941
14.
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry.
Crit Care Med
; 49(8): 1293-1302, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-33861557
15.
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.
J Card Fail
; 27(10): 1073-1081, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34625127
16.
Epidemiology and causes of cardiogenic shock.
Curr Opin Crit Care
; 27(4): 401-408, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-34010224
17.
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician.
Circulation
; 140(24): 2019-2037, 2019 12 10.
Article
in English
| MEDLINE | ID: mdl-31815538
18.
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
Circulation
; 139(3): 366-375, 2019 01 15.
Article
in English
| MEDLINE | ID: mdl-30586726
19.
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.
Stroke
; 51(5): 1546-1554, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32312223
20.
A current review of COVID-19 for the cardiovascular specialist.
Am Heart J
; 226: 29-44, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32497913